The Trans-Pacific Partnership — Is It Bad for Your Health?
Several leaked chapters of the Trans-Pacific Partnership Agreement indicate that it could have a substantial effect on health, largely by increasing the costs of medications in both low-income and high-income countries. International trade deals once focused primarily on tariffs. As a result, they h...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2015-07, Vol.373 (3), p.201-203 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Several leaked chapters of the Trans-Pacific Partnership Agreement indicate that it could have a substantial effect on health, largely by increasing the costs of medications in both low-income and high-income countries.
International trade deals once focused primarily on tariffs. As a result, they had little direct effect on health, and health experts could reasonably leave their details to trade professionals. Not so today. Modern trade pacts have implications for a wide range of health policy issues, from medicine prices to tobacco regulation, not only in the developing world but also in the United States.
The Trans-Pacific Partnership Agreement (TPP) is a case in point. A massive trade deal now reportedly on the verge of completion, the TPP has nearly 30 chapters. A draft chapter on intellectual property (IP) alone runs 77 . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMp1506158 |